Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron
1 Ansichten
• 06/15/23
0
0
Einbetten
administrator
Abonnenten
A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare